監管毒理學和藥理學 SCIE

期刊簡介預計審稿時間： 約3月 約9.5周

Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.

Types of peer-reviewed articles published:

-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:

1.Factors influencing human sensitivity

2.Exposure science related to risk assessment

3.Alternative toxicological test methods

4.Frameworks for evaluation and integration of data in regulatory evaluations

5.Harmonization across regulatory agencies

6.Read-across methods and evaluations

-Contemporary Reviews on policy related Research issues

-Letters to the Editor

-Guest Editorials (by Invitation)

《監管毒理學和藥理學》發表同行評審文章，涉及實驗動物和人類數據的生成、評估和解釋，這些數據對于社會毒理學和藥理學法規的監管機構具有直接重要性和相關性。所有發表的同行評審文章都應致力于改善對人類健康和環境的保護。歡迎評論和討論，以科學為基礎解決與毒理學和藥理學化合物風險評估和管理有關的法律和/或監管決策。它面向國際讀者，包括科學家、風險評估人員和管理者，以及其他活躍于人類和環境健康領域的專業人士。

發表的同行評審文章類型：

-與監管方面相關的原創研究文章，涵蓋的方面包括但不限于：

1.影響人類敏感性的因素

2.與風險評估相關的暴露科學

3.替代毒理學測試方法

4.監管評估中數據評估和整合的框架

5.監管機構之間的協調

6.跨閱讀方法和評估

-政策相關研究問題的當代評論

-致編輯的信

-客座社論（受邀）

《Regulatory Toxicology And Pharmacology》(監管毒理學和藥理學)編輯部通訊方式為ACADEMIC PRESS INC ELSEVIER SCIENCE, 525 B ST, STE 1900, SAN DIEGO, USA, CA, 92101-4495。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。